Datos Health: Feasibility, Safety, and Effectiveness of a Mobile Application Study Shows Datos’ TeleHealth Platform Improves Cardiac Rehab and Patient Adherence

June 30, 2020

Datos Health, a provider of hospital-grade automated remote care and telemedicine platforms, announced today the results of new research with Sheba Medical Center, showing that tele-cardiac rehabilitation (tele-CR) can improve adherence and exercise capacity among cardiac rehabilitation (CR) patients.

The clinical study, Feasibility, Safety, and Effectiveness of a Mobile Application in Cardiac Rehabilitation, published in the Israel Medical Association Journal (IMAJ), evaluated clinical and physiological outcomes, as well as patient adherence, to assess the viability of tele-CR as an alternative option to center-based rehabilitation. The six-month trial, performed with Sheba’s Cardiac Rehabilitation Center, is the first attempt to utilize digital health technology for remotely monitored cardiac rehabilitation.

“Despite the clear benefits of CR in reducing cardiac mortalities and improving the overall quality of life, it is often woefully underutilized for reasons including challenges in attending rehabilitation centers and interference with day-to-day life,” said Prof. Robert Klempfner, MD, Director of the Israeli Center for Cardiovascular Research and Scientific Director of the ARC Innovation Center at Sheba Medical Center. “The findings of this study reveal considerable advantages of tele-CR in the increase of adherence to exercise programs and improved patient outcomes.

The versatility of Datos’ remote care platform and its ability to increase patient engagement and adherence through personalization of the application is integral to making tele-CR a viable option for patients unable or unwilling to participate in center-based CR programs.”

Study results revealed significant improvement in exercise capacity and consistent adherence among patients, with over 63% completing the goal of 150 minutes of aerobic exercise per week. Overall patient satisfaction with the program was favorable, with a score of 4.05 out of 5. The success of the project resulted in the Israeli Ministry of Health defining a new reimbursement code for cardiac rehabilitation.

Patients received a smartphone application with a customized care plan, and monitoring devices that provided personalized feedback following each training session. Datos developed the application and accompanying care team dashboard to provide remote patient monitoring and continuity of care throughout the program. A dedicated care management portal provided care teams with information on patient adherence and progress.

“Remote care and telemedicine solutions are helping health systems to reduce costs and improve recovery through increased engagement between patients and their care teams outside of hospital settings,” said Uri Bettesh, CEO and Founder of Datos Heath. “As shown by the Ministry of Health’s actions, this can also effect positive regulatory change. However, success of such programs is dependent on developing strong partnerships between healthcare organizations and technology developers. Datos has enjoyed a long-standing relationship with Prof. Klempfner and his team at Sheba. This collaboration is further evidence of how together we can bring positive change to the provision of care for the benefit of large patient populations.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version